Administrative Core and Senior Leadership - Project Summary/Abstract The Cold Spring Harbor Laboratory Cancer Center is led by Bruce Stillman, Ph.D. (Gene Regulation and Cell Proliferation Program), David Tuveson, M.D., Ph.D. (Signal Transduction Program), Nicholas Tonks, Ph.D. (Signal Transduction Program), and Denise Roberts, Ph.D. (Administration). Stillman has been the Director of the CSHL Cancer Center since 1992, while concurrently holding the position of President of Cold Spring Harbor Laboratory. As Director, he is responsible for the overall direction, planning and fundraising to support cancer research and the Shared Resources. He is assisted in oversight of the Cancer Center by three Deputy Directors: Tuveson, Tonks, and Roberts. Tuveson, Deputy Director for Programs, is primarily responsible for oversight of the cancer research Programs and recruitment of new members to the Cancer Center. Tonks, Deputy Director for Shared Resources, supervises all the Shared Resource leaders, acts as a liaison between faculty, scientific staff and Shared Resource personnel, and provides leadership to maintain the highest quality scientific services. Roberts, Deputy Director for Administration, coordinates all administrative services on behalf of the Cancer Center, coordinates the Executive Committee of the Cancer Center and, with Tonks, oversees the Shared Resources. These four senior leaders are committed to maintaining and continually improving CSHL as a premier center for cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA045508-33
Application #
9975707
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
33
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Banito, Ana; Li, Xiang; Laporte, Aimée N et al. (2018) The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell 33:527-541.e8
Stacchiotti, Silvia; Mir, Olivier; Le Cesne, Axel et al. (2018) Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma. Oncologist 23:62-70
Hwang, Dong-Woo; Jaganathan, Anbalagan; Shrestha, Padmina et al. (2018) Chromatin-mediated translational control is essential for neural cell fate specification. Life Sci Alliance 1:e201700016
Goncalves, Marcus D; Hwang, Seo-Kyoung; Pauli, Chantal et al. (2018) Fenofibrate prevents skeletal muscle loss in mice with lung cancer. Proc Natl Acad Sci U S A 115:E743-E752
Biffi, Giulia; Oni, Tobiloba E; Spielman, Benjamin et al. (2018) IL-1-induced JAK/STAT signaling is antagonized by TGF-beta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov :
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554:378-381
Aznarez, Isabel; Nomakuchi, Tomoki T; Tetenbaum-Novatt, Jaclyn et al. (2018) Mechanism of Nonsense-Mediated mRNA Decay Stimulation by Splicing Factor SRSF1. Cell Rep 23:2186-2198
Xie, Yuanyuan; Cao, Zhen; Wong, Elissa Wp et al. (2018) COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors. J Clin Invest 128:1442-1457
Lin, Kuan-Ting; Ma, Wai Kit; Scharner, Juergen et al. (2018) A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma. Genome Res :
Fang, Han; Huang, Yi-Fei; Radhakrishnan, Aditya et al. (2018) Scikit-ribo Enables Accurate Estimation and Robust Modeling of Translation Dynamics at Codon Resolution. Cell Syst 6:180-191.e4

Showing the most recent 10 out of 380 publications